Fibrates vs control
Death from any cause during the treatment and scheduled · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in death from any cause during the treatment and scheduled compared with control (low certainty).
2 findings from 1 review
- Fibrates for secondary prevention of cardiovascular disease and stroke 2015 · Cochrane Headline outcomes onlyRR 0.98 [0.91, 1.06]10 studies · 13653 participantsLow
- Fibrates for secondary prevention of cardiovascular disease and stroke 2015 · Cochrane Headline outcomes onlyRR 1.01 [0.91, 1.12]5 studies · 7909 participantsLow